On June 6th, Gelonhui reported that Zhejiang East-Asia Pharmaceutical (605177.SH) received a notification from Mr. Chi Zhengming that from May 24th, 2024 to June 6th, 2024, Mr. Chi Zhengming transferred 712,000 shares of 'East-Asia Convertible Bonds' through bulk trading, accounting for approximately 10.32% of the total convertible bonds issued. After the transfer, the company's controlling shareholder, actual controller and the actual controller's persons acting in concert hold a total of 1.12046 million shares of 'East-Asia Convertible Bonds', accounting for approximately 16.24% of the total convertible bonds issued.
东亚药业(605177.SH)：池正明累计转让“东亚转债”71万张
Zhejiang East-Asia Pharmaceutical (605177.SH): Chi Zhengming has transferred a total of 710,000 East-Asia Convertible Bonds.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.